Peter F. Troke
Broadstairs, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 24, 2019
Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.
Journal: Cellular microbiology
Published: April 22, 2016
Tissue penetration of antifungal agents.
Journal: Clinical microbiology reviews
Published: January 08, 2014
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Journal: PloS one
Published: October 25, 2013
Improvement in the outcome of invasive fusariosis in the last decade.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: June 03, 2013
An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity.
Journal: The Journal of antimicrobial chemotherapy
Published: April 06, 2013
Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis.
Journal: Journal of clinical microbiology
Published: May 04, 2012
The efficacy of voriconazole in 24 ocular Fusarium infections.
Journal: Infection
Published: January 06, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026